The results of KEGG analysis showed that the mechanism of action of AMS in treating sleep disorders mainly involves the dopamine synaptic pathway, the neuroactive ligand–receptor interaction, the renin-angiotensin system, the synaptic vesicle cycle pathway, and other signaling pathways. Here, REN is linked to ablepharon macrostomia syndrome.